This incident came five months after the FDA had inspected the Reckitt plant, where the formula was manufactured, and detected the deadly bacteria. While no illnesses from the batches have been reported, the Center for Disease Control and Prevention (CDC) has warned that Cronobacter can be deadly for young infants, with symptoms ranging from fever and poor feeding to seizures and bloodstream infections.
In response to the recall, an FDA spokesperson stated that the agency had limited the scope of the product recall, noting that it was much narrower than the Abbott recall in 2021, which led to at least four infant illnesses, including two deaths, and the shutdown of an Abbott Nutrition Michigan production plant.
WATCH: THE FASCINATING STORY OF BRIDGETTE GABRIEL
March 28, 2023
The FDA has since come under scrutiny by House Republicans, who have launched an investigation into the agency's handling of the baby formula shortage, calling on FDA Commissioner Robert Califf to provide more information regarding their "poor response" to the situation.
WATCH: JIMMY FALLON MOCKS UPCOMING PRESIDENTIAL DEBATE
The FDA needs to take precautionary measures to ensure the safety of infant formula products. As part of their oversight, the agency must continue to engage with manufacturers to limit the scope of recalls and minimize disruptions to the market. Furthermore, the FDA must work to improve its response to whistleblower complaints and provide timely and accurate information to the public.